Everyone Healthy Library
Fungal Urinary Tract Infections
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Linked signs and symptoms
7Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
1Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
18Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Medical therapy
2Alternative and complementary therapies
6- Echinacea PurpureaNo Recommendation(Moderate Evidence)
- Goldenseal (Hydrastis Canadensis)Weakly Against(Low Evidence)
- Gotu Kola (Centella Asiatica, Hydrocotyle Asiatica)No Recommendation(Low Evidence)
- Kava (Piper Methysticum)No Recommendation(Very Low Evidence)
- Pau Darco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla)Strongly Against(Very Low Evidence)
- Pokeweed Antiviral Protein (PAP)No Recommendation(Very Low Evidence)
Alternative medicine
5- Goldenseal (Hydrastis Canadensis)Weakly Against(Low Evidence)
- Gotu Kola (Centella Asiatica, Hydrocotyle Asiatica)No Recommendation(Low Evidence)
- Kava (Piper Methysticum)No Recommendation(Very Low Evidence)
- Pau Darco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla)Strongly Against(Very Low Evidence)
- Pokeweed Antiviral Protein (PAP)No Recommendation(Very Low Evidence)
Vitamins and minerals
1Vitamins
1Linked diagnostic tests and investigations
31These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Alpha-1 Antitrypsin (AAT) Concentration
- Cerebrospinal Fluid Albumin Concentration
- Cerebrospinal Fluid Glucose Concentration
- Cerebrospinal Fluid Protein Concentration
- Cerebrospinal Fluid Protein Electrophoresis
- Cerebrospinal Fluid White Cell Differential
- Chloride Concentration (Blood)
- Cholesterol Concentration
- Cholinesterase (Serum Acetylcholinesterase, Pseudocholinesterase)
- D-Dimer Blood Test
- Ferritin Concentration
- Fibrin Degradation Products (FDPs, Fibrin Split Products, FSPs, Fibrin Breakdown Products, Fbps)
- Fibrin Monomers Test
- Fibrinopeptide A (FPA) Action Assay
- Glucagon Concentration Test
- Glucose 6 Phosphate Dehydrogenase (G6PD) Concentration
- Glucose, Blood (Random Blood Glucose Test)
- haptoglobin (Hp) concentration
- Neutrophil Absolute Count
- Plasminogen Activity
- Potassium Concentration (K, Blood)
- Prostate-Specific Antigen (PSA) Blood Test
- Protein Electrophoresis (Blood, Serum Protein)
- Urine Crystal Concentration
- Urine glucose concentration
- Urine Granular Cast Concentration
- Urine Haemologlobin (Hb) Concentration
- Urine Leukocyte Esterase Screening
- Urine pH Test
- Urine Red Blood Cells Concentration
- White Blood Cell (WBC) Count
Biological and test markers
34This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
28- Albumin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 10–35 mg/dL; All: 56–76 %Linked diagnostic tests2Cerebrospinal Fluid Albumin Concentration, Cerebrospinal Fluid Protein Electrophoresis
- Alpha-1 Antintrypsin (AAT)Reference range exampleAdult ( > 16y): 90–215 mg/dLLinked diagnostic tests1Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-1-Globulin (Blood, Serum)Reference range exampleAll: 0.1–0.3 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Alpha-2-Globulin (Blood, Serum)Reference range exampleAll: 0.6–1 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Cerebrospinal Fluid LeukocytesReference range exampleAdult ( > 16y): 0–5 /µL; 1y - 6y: 0–20 /µLLinked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Total ProteinReference range exampleAdult ( > 16y): 15–45 mg/dL; Child (< 10y): 15–70 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Protein Concentration
- Cholesterol (Total)Reference range exampleInfant (0 - 1y): 75–180 mg/dL; Adult ( > 16y): 0–190 mg/dLLinked diagnostic tests1Cholesterol Concentration
- D-DimerReference range exampleAdult ( > 16y): 0–240 µg/LLinked diagnostic tests1D-Dimer Blood Test
- FerritinReference range exampleChild (0 - 16y): 7–140 µg/L; Adult ( > 16y), Female: 18–160 µg/LLinked diagnostic tests1Ferritin Concentration
- Fibrin MonomersReference range example0–10,000 µg/LLinked diagnostic tests1Fibrin Monomers Test
- Fibrin Split ProductsReference range exampleAll: 0–1 mg/dLLinked diagnostic tests1Fibrin Degradation Products (FDPs, Fibrin Split Products
- Fibrinopeptide A (FPA)Reference range exampleAdult ( > 16y), Female: 0.7–3.1 mg/mL; Adult ( > 16y), Male: 0.35–2.5 mg/mLLinked diagnostic tests1Fibrinopeptide A (FPA) Action Assay
- Forced Expiratory Volume At Three Seconds (FEV3)Reference range exampleAll: 95–100 %Linked diagnostic tests1Spirometry
- Gamma Globulin (Blood, Serum)Reference range exampleAll: 0.8–1.7 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- GlucagonReference range exampleChild (0 - 16y): 0–147 pg/mL; Adult ( > 16y): 20–110 pg/mLLinked diagnostic tests1Glucagon Concentration Test
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic tests1haptoglobin (Hp) concentration
- PlasminogenReference range exampleAdult ( > 16y), Female: 65–153 %; Adult ( > 16y), Male: 70–120 %Linked diagnostic tests1Plasminogen Activity
- Potassium (K, Blood)AbbreviationKReference range exampleInfant (0 - 1y): 4.1–5.3 mEq/L; Child (0 - 16y): 3.4–4.7 mEq/LLinked diagnostic tests1Potassium Concentration (K, Blood)
- PrealbuminReference range exampleAll: 2–7 %Linked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
- Prostate Specific Antigen (PSA)Reference range exampleAdult ( > 16y), Male: 0–3.8 ng/mLLinked diagnostic tests1Prostate-Specific Antigen (PSA) Blood Test
- Triple Phosphate Crystals (Urine)Reference range exampleAll: 0–1 Not PresentLinked diagnostic tests1Urine Crystal Concentration
- Unrine Granular CastsReference range exampleAdult ( > 16y): 0–0 Not PresentLinked diagnostic tests1Urine Granular Cast Concentration
- Urine Crystals (Total)Reference range example0–2 /hpfLinked diagnostic tests1Urine Crystal Concentration
- Urine glucoseReference range example0–2.5; Adult ( > 16y): 0–2.5 mmol/dayLinked diagnostic tests1Urine glucose concentration
- Urine Haemoglobin (Hb)Reference range exampleAdult ( > 16y): 0–0.02 mg/dLLinked diagnostic tests1Urine Haemologlobin (Hb) Concentration
- Urine Leukocyte EsteraseReference range exampleAll: 0–1 Not PresentLinked diagnostic tests1Urine Leukocyte Esterase Screening
- Urine Red Blood CellsReference range exampleAdult ( > 16y): 0–2 /hpfLinked diagnostic tests1Urine Red Blood Cells Concentration
- White Blood Cell (WBC)Reference range exampleAdult ( > 16y): 4.5–10.5 million/mL; Adult ( > 16y): 3.2–10 million/mLLinked diagnostic tests1White Blood Cell (WBC) Count
Often decreased
6- Chloride (Blood, Cl)Reference range exampleAdult ( > 16y): 97–106 mEq/L; Birth - 2wks: 94–106 mEq/LLinked diagnostic tests1Chloride Concentration (Blood)
- CholinesteraseReference range exampleAll: 6–19 U/mLLinked diagnostic tests1Cholinesterase (Serum Acetylcholinesterase, Pseudocholinesterase)
- Glucose (Blood)Reference range exampleInfant (0 - 1y): 3–6.1 mmol/L; Adult ( > 16y): 0–6.1 mmol/LLinked diagnostic tests11fasting Blood Glucose Test, Glucose Tolerance Test (GTT
- Glucose (Cerebrospinal Fluid)Reference range exampleChild (0 - 16y): 65–85 mg/dL; Adult ( > 16y): 50–72 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Glucose Concentration
- Glucose 6 Phosphate Dehydrogenase (G6PD)Reference range exampleAdult ( > 16y): 10.1–18.5 U/gHb; Birth - 2wks: 12–23 U/gHbLinked diagnostic tests1Glucose 6 Phosphate Dehydrogenase (G6PD) Concentration
- UrineReference range exampleAdult ( > 16y): 4.5–7.5; Child (0 - 16y): 500–1,400 mLLinked diagnostic tests5Urine Colour, Urine Creatinine Concentration
Other associated markers
0No markers in this group.
Introduction / full article
Fungal Urinary Tract Infections
Fungal Urinary Tract Infections
This is a fungal infection that usually affects the kidneys and bladder. Fungal infection in the lower urinary tract is usually a side effect of the usage of urinary catheters and antibiotic therapy. There are rarely any symptoms when someone has a fungal urinary tract infection in the lower urinary track, though some patients experience pain while urinating or frequent urges to urinate. Traces of blood in the urine can also be found. There is also a type of fungal urinary tract infection that is called Renal Candidiasis, which involves the gastrointestinal tract.
Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Vitamin A [1, 31, 32, 33, 34, 35, 36, 37]:
Please note, this management does NOT treat the condition itself. It may mildly help in preventing some of the symptoms, and even then has insufficient evidence to back up this claim at present. Please note, this acts as a PREVENTATIVE treatment, and not necessarily symptomatic relief.
Recommendation: Strongly in favor (Vitamin A may help to prevent urinary tract infections due to its role in the body's immune function)
Grade of Evidence: high quality of evidence
Pokeweed Antiviral Protein (PAP) [1, 26, 27, 28, 29, 30]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present. Warning! All parts of the plant, Pokeweed (Phytolacca Americana), is poisonous and should not be ingested. Thoroughly cooking the plant reduces that toxicity. The effects of the improperly prepared plant include vomiting, diarrhoea, cramps, headache, confusion, convulstions, low blood pressure, heart block and death. Only plant extracts (PAP) or thoroughly prepared plants should be ingested, and even then, under professional medical guidance.
Recommendation: no recommendation (There is insufficient evidence to support claims that PAP helps to treat fungal infections)
Grade of Evidence: very low of evidence
Pau D'Arco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla) [1, 25]:
Please note, this treatment has potentially serious side effects. Some of the chemicals in the plant are known to be toxic. High doses are known to cause liver and kidney. Even at low doses, chemicals in the plant may interfere with blood clotting, causing excess bleeding and anaemia. Pau D'Arco should be avoided, especially by pregnant or breastfeeding women.
Recommendation: Strongly against (There is insufficient evidence to support claims that Pau D'arco helps to treat fungal infections. This, combined with its potentially harmful side effects if taken without supervision from a doctor or pharmacist gives enough reason to avoid this treatment.)
Grade of Evidence: very low quality of evidence
* www.gradeworkinggroup.org
Kava (Piper Methysticum) [1, 21, 22, 23, 24]:
WARNING: In rare cases, kava may lead to liver failure and other life threatening problems. The FDA warns that those who have had liver problems, or are on medicacations which may affect the liver, patients should check with their doctors before taking Kava. Other side effects include headache, upset stomach, drowsiness, weight loss, bloody urine, and muscle weakness.
Recommendation: No recommendation (There is insufficient evidence to support claims that Kava helps to treat symptoms of Fungal Infection. More research is needed)
Grade of Evidence: Very low quality of evidence
Gotu Kola (Centella Asiatica, Hydrocotyle Asiatica) [3, 15, 16, 17, 18, 19, 20]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: no recommendation (There is insufficient evidence to support claims that Gotu Kola helps in the treatment of Fungal Urinary Tract Infections in any way. More research is needed.)
Grade of Evidence: low quality of evidence
Goldenseal (Hydrastis Canadensis) [3, 8, 9, 10, 11, 12, 13, 14]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly against (There is insufficient evidence to support claims that Goldenseal helps to treat Urinary Tract Infections. More studies are needed. Goldenseal may produce toxic effects, including depression, constipation, rapid heartbeat, stomach pain, mouth ulcers and vomiting.)
Grade of Evidence: low quality of evidence
Echinacea Purpurea [3, 4, 5, 6, 7]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: no recommendation (Evidence has shown that Echinacea has no effect in the treatment or prevention of urinary tract infections)
Grade of Evidence: moderate quality of evidence
* www.gradeworkinggroup.org
Summary Reference
Treatments:
1. Malani AN, Kauffman CA. Candida urinary tract infections: treatment options. Expert Rev Anti Infect Ther. 2007 Apr;5(2):277-84.
2. Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol. 1999 Dec;17(6):410-4.
3. Ades T, Alteri R, Gansler T, Yeargin P, "Complete Guide to Complimentary & Alternative Cancer Therapies", American Cancer Society, Atlanta USA, 2009
4. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/echinacea
5. http://nccam.nih.gov/health/echinacea/ataglance.htm
6. http://www.ncbi.nlm.nih.gov/pubmed/16049208
7. http://www.medicalnewstoday.com/articles/29145.php
8. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/goldenseal
9. http://nccam.nih.gov/health/goldenseal/
10. Tierra Michael (1998): The Way of Herbs. New York, Pocket Books
11. Grieve M. (1971): A Modern Herbal. New York, Dover Publications, Inc
12. Mills S. and Bone K. (2000): Principles and Practice of Phytotherapy. Philadelphia, Churchill Livingstone
13. Tice Raymond (1997): Goldenseal and Two of its constituent alkaloids: berberine and hydrastine Research Triangle Park, National Institute of Environmental Health Sciences, in Seiger E: Review of Toxilogical Literature
14. http://www.henriettesherbal.com/eclectic/ellingwood/hydrastis.html
15. Winston, D., Maimes, S., Adaptogens: Herbs For Strength, Stamina, and Stress Relief, 2007, pp. 226-7
16. "A Double-Blind, Placebo-Controlled Study on the Effects of Gotu Kola (Centella asiatica) on Acoustic Startle Response in Healthy Subjects". Journal of Clinical Psychopharmacology. 20(6):680-684, December 2000. Bradwejn, Jacques MD, FRCPC *; Zhou, Yueping MD, PhD ++; Koszycki, Diana PhD *; Shlik, Jakov MD, PhD
17 B. M. Hausen (1993) "Centella asiatica (Indian pennywort), an effective therapeutic but a weak sensitizer." Contact Dermatitis 29 (4), 175–179 doi:10.1111/j.1600-0536.1993.tb03532.x
18. Cataldo, A., Gasbarro, V., et al., "Effectiveness of the Combination of Alpha Tocopherol, Rutin, Melilotus, and Centella asiatica in The Treatment of Patients With Chronic Venous Insufficiency", Minerva Cardioangiology, 2001, Apr; 49(2):159-63
19. http://en.wikipedia.org/wiki/Gotu_kola#Medicinal_effects
20. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/gotu-kola
21. http://www.publish.csiro.au/?act=view_file&file_id=SP05005.pdf
22. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/kava
23. http://www.kavazen.com/pages/library.htm#KavaZen and Kava Safety
24. http://nccam.nih.gov/health/kava/index.htm
25. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/pau-d-arco
26. http://www.cbif.gc.ca/pls/pp/ppack.info?p_psn=12&p_type=all&p_sci=sci&p_x=px
27. http://www.pfaf.org/user/Plant.aspx?LatinName=Phytolacca+americana
28. http://www.ncbi.nlm.nih.gov/pubmed/315368
29. http://www.nlm.nih.gov/medlineplus/ency/article/002874.htm
30. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/pokeweed
31. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-vitamina.html
32. http://www.nlm.nih.gov/medlineplus/vitamina.html
33. http://ods.od.nih.gov/factsheets/vitamina.asp
34. http://www.who.int/nutrition/topics/vad/en/
35. Latham, Michael E. (1997). Human Nutrition in the Developing World (Fao Food and Nutrition Paper). Food & Agriculture Organization of the United. ISBN 92-5-103818-X.
36. Sommer, Alfred (1995). Vitamin a Deficiency and Its Consequences: A Field Guide to Detection and Control. Geneva: World Health Organization. ISBN 92-4-154478-3.
37. http://www.unicef.org/worldfitforchildren/files/A-RES-S27-2E.pdf